Abstract
G protein-coupled receptors (GPCRs) play critical roles in cellular signal transduction and are important targets for therapeutics. Although these receptors have been intensely studied for quite some time, our understanding about their mechanism of action is still incomplete. GPCR activity has traditionally been viewed within the context of two-state models where the receptor is in equilibrium between a single inactive state and a single active state. This framework is too simple and restrictive to accommodate more recent observations made on these receptors, which instead point to a situation where the receptor can adopt several different active conformational substates with distinct functional effects. Structural and functional evidence for this emerging view is presented in this review. Implications of this emerging view in rationalizing diseased states and in drug discovery are also discussed.
Keywords: Conformational substates, drug action, functional selectivity, receptor activation, receptor pharmacology, membrane protein, signal transduction, two-state model, allosteric effect, ambiguous
Current Medicinal Chemistry
Title: Ensemble of G Protein-Coupled Receptor Active States
Volume: 19 Issue: 8
Author(s): P. S.-H. Park
Affiliation:
Keywords: Conformational substates, drug action, functional selectivity, receptor activation, receptor pharmacology, membrane protein, signal transduction, two-state model, allosteric effect, ambiguous
Abstract: G protein-coupled receptors (GPCRs) play critical roles in cellular signal transduction and are important targets for therapeutics. Although these receptors have been intensely studied for quite some time, our understanding about their mechanism of action is still incomplete. GPCR activity has traditionally been viewed within the context of two-state models where the receptor is in equilibrium between a single inactive state and a single active state. This framework is too simple and restrictive to accommodate more recent observations made on these receptors, which instead point to a situation where the receptor can adopt several different active conformational substates with distinct functional effects. Structural and functional evidence for this emerging view is presented in this review. Implications of this emerging view in rationalizing diseased states and in drug discovery are also discussed.
Export Options
About this article
Cite this article as:
S.-H. Park P., Ensemble of G Protein-Coupled Receptor Active States, Current Medicinal Chemistry 2012; 19(8) . https://dx.doi.org/10.2174/092986712799320619
DOI https://dx.doi.org/10.2174/092986712799320619 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
New Recombinant Serotypes of AAV Vectors
Current Gene Therapy The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer
Current Medicinal Chemistry Radiation Protection of the Child from Diagnostic Imaging
Current Pediatric Reviews Research Progress of the UPR Mechanism and its Effect on Improving Foreign Protein Expression
Protein & Peptide Letters Non-Covalent Proteasome Inhibitors
Current Pharmaceutical Design Rikkunshito and Ghrelin Secretion
Current Pharmaceutical Design Nucleic Acids Electro-transfer: From Bench to Bedside
Current Drug Metabolism Protective Effect of Perindopril on Tumor Progression and Angiogenesis in Animal Model of Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry β-Galactosidase and Galactooligosaccharides Production and Applications
Recent Patents on Chemical Engineering Regulation of Microtubule: Current Concepts and Relevance to Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Cobra Cardiotoxins: Membrane Interactions and Pharmacological Potential
Current Medicinal Chemistry XSTING, Software for Evaluation of Radiotherapy Planning Performed Using EGSnrcMP Codes
Current Medical Imaging Phosphorothioate Oligonucleotides: Effectiveness and Toxicity
Current Drug Targets MMP14 Regulates VEGFR3 Expression on Corneal Epithelial Cells
Protein & Peptide Letters Targeted Multimodal Liposomes for Nano-delivery and Imaging: An Avenger for Drug Resistance and Cancer
Current Gene Therapy Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules
Current Drug Targets Targeted Liposomal Drug Delivery in Cancer
Current Pharmaceutical Design Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases
Current Pharmaceutical Biotechnology New Trends in Biological Activities and Clinical Studies of Quinolinic Analogues: A Review
Current Drug Targets From Proteins to Nucleic Acid-Based Drugs: The Role of Biotech in Anti-VEGF Therapy
Anti-Cancer Agents in Medicinal Chemistry